LivaNova (LIVN) EBT Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 10,721.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,721.00 |
| Dec 31, 2025 | -989.00 |
| Sep 30, 2025 | -449.00 |
| Jun 30, 2025 | 268.00 |
| Mar 31, 2025 | -8,802.00 |
| Dec 31, 2024 | 4,795.00 |
| Sep 30, 2024 | 1,466.00 |
| Jun 30, 2024 | 498.00 |
| Mar 31, 2024 | -1,530.00 |
| Dec 31, 2023 | -3,273.00 |
| Sep 30, 2023 | 4,131.00 |
| Jun 30, 2023 | -568.00 |
| Mar 31, 2023 | 139.00 |
| Dec 31, 2022 | 318.00 |
| Sep 30, 2022 | -2,559.00 |
| Jun 30, 2022 | 2,734.00 |
| Mar 31, 2022 | 1,366.00 |
| Dec 31, 2021 | 11,105.00 |
| Sep 30, 2021 | -862.00 |
| Jun 30, 2021 | -797.00 |
| Mar 31, 2021 | -886.00 |
| Dec 31, 2020 | -5,876.00 |
| Sep 30, 2020 | -1,579.00 |
| Jun 30, 2020 | 94.00 |
| Mar 31, 2020 | 608.00 |
| Dec 31, 2019 | 4,092.00 |
| Sep 30, 2019 | 1,127.00 |
| Jun 30, 2019 | -1,935.00 |
| Mar 31, 2019 | -1,737.00 |
| Dec 31, 2018 | -9,690.00 |
| Sep 30, 2018 | -1,496.00 |
| Jun 30, 2018 | -1,811.00 |
| Mar 31, 2018 | -39.00 |
| Dec 31, 2017 | -613.00 |
| Sep 30, 2017 | 275.00 |
| Jun 30, 2017 | 1,633.00 |
| Mar 31, 2017 | 2,648.00 |
| Oct 18, 2015 | -7,514.00 |